Blinded, Randomized Study of Gabapentin (Neurontin(R)) and Gabapentin Enacarbil (Horizant(TM)) in Restless Leg Syndrome
Phase of Trial: Phase IV
Latest Information Update: 04 Jul 2016
Price : $35 *
At a glance
- Drugs Gabapentin (Primary) ; Gabapentin enacarbil (Primary)
- Indications Restless legs syndrome
- Focus Therapeutic Use
- 28 Jun 2016 Status changed from recruiting to discontinued.
- 11 Apr 2016 Planned End Date changed from 1 Oct 2015 to 1 Dec 2016.
- 11 Apr 2016 Planned primary completion date changed from 1 Oct 2015 to 1 Dec 2016.